Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The use of 1E12, a monoclonal anti-platelet factor 4 antibody, to improve the diagnosis of vaccine-induced immune thrombotic thrombocytopenia.
Vayne C, Rollin J, Clare R, Daka M, Atsouawe M, Guéry EA, Cauchie P, Cordonnier C, Cuisenier P, De Maistre E, Donnard M, Drillaud N, Faille D, Galinat H, Gouin-Thibault I, Lemoine S, Mourey G, Mullier F, Siguret V, Susen S, Godon A, Nazy I, Gruel Y, Pouplard C. Vayne C, et al. Among authors: siguret v. J Thromb Haemost. 2024 Aug;22(8):2306-2315. doi: 10.1016/j.jtha.2024.05.005. Epub 2024 May 16. J Thromb Haemost. 2024. PMID: 38762021 Free article.
C-reactive protein and D-dimer in cerebral vein thrombosis: Relation to clinical and imaging characteristics as well as outcomes in a French cohort study.
Billoir P, Siguret V, Fron EM, Drouet L, Crassard I, Marlu R, Barbieux-Guillot M, Morange PE, Robinet E, Metzger C, Wolff V, André-Kerneis E, Klapczynski F, Martin-Bastenaire B, Pico F, Menard F, Ellie E, Freyburger G, Rouanet F, Allano HA, Godenèche G, Mourey G, Moulin T, Berruyer M, Derex L, Trichet C, Runavot G, Le Querrec A, Viader F, Cluet-Dennetiere S, Husein TT, Donnard M, Macian-Montoro F, Ternisien C, Guillon B, Laplanche S, Zuber M, Peltier JY, Tassan P, Roussel B, Canaple S, Scavazza E, Gaillard N, Triquenot Bagan A, Le Cam Duchez V. Billoir P, et al. Among authors: siguret v. Res Pract Thromb Haemost. 2023 Mar 28;7(3):100130. doi: 10.1016/j.rpth.2023.100130. eCollection 2023 Mar. Res Pract Thromb Haemost. 2023. PMID: 37138790 Free PMC article.
Is there a role for the laboratory monitoring in the management of specific antidotes of direct oral anticoagulants?
Gendron N, Billoir P, Siguret V, Le Cam-Duchez V, Proulle V, Macchi L, Boissier E, Mouton C, De Maistre E, Gouin-Thibault I, Jourdi G; French Society on Thrombosis and Haemostasis. Gendron N, et al. Among authors: siguret v. Thromb Res. 2024 May;237:171-180. doi: 10.1016/j.thromres.2024.04.005. Epub 2024 Apr 10. Thromb Res. 2024. PMID: 38626592 Free article. Review.
Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors.
Schreuder M, Jourdi G, Veizaj D, Poole DA 3rd, Cheung KL, Poenou G, Verhoef D, Thomassen S, Janssen LFH, Stepanian A, Hackeng TM, Gaussem P, Reitsma PH, Geerke DP, Siguret V, Bos MHA. Schreuder M, et al. Among authors: siguret v. J Thromb Haemost. 2024 Aug;22(8):2211-2226. doi: 10.1016/j.jtha.2024.04.022. Epub 2024 May 9. J Thromb Haemost. 2024. PMID: 38729577 Free article.
Evaluation of hemostasis understanding in medical and pharmacy students from a Parisian university.
Gendron N, Helley D, Rousselot P, Siguret V, Gaussem P, James C, Khider L, Ajzenberg N, Boissier E, Boissel N, Smadja DM, Planquette B. Gendron N, et al. Among authors: siguret v. Res Pract Thromb Haemost. 2024 Aug 22;8(6):102547. doi: 10.1016/j.rpth.2024.102547. eCollection 2024 Aug. Res Pract Thromb Haemost. 2024. PMID: 39309230 Free PMC article. No abstract available.
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial.
Zuily S, Lefèvre B, Sanchez O, Empis de Vendin O, de Ciancio G, Arlet JB, Khider L, Terriat B, Greigert H, Robert CS, Louis G, Trinh-Duc A, Rispal P, Accassat S, Thiery G, Montani D, Azarian R, Meneveau N, Soudet S, Le Mao R, Maurier F, Le Moing V, Quéré I, Yelnik CM, Lefebvre N, Martinot M, Delrue M, Benhamou Y, Parent F, Roy PM, Presles E, Goehringer F, Mismetti P, Bertoletti L, Rossignol P, Couturaud F, Wahl D, Thilly N, Laporte S; COVI-DOSE investigators. Zuily S, et al. EClinicalMedicine. 2023 Jun;60:102031. doi: 10.1016/j.eclinm.2023.102031. Epub 2023 Jun 9. EClinicalMedicine. 2023. PMID: 37350990 Free PMC article.
Safety profile of tinzaparin versus subcutaneous unfractionated heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis: the Innohep® in Renal Insufficiency Study (IRIS).
Leizorovicz A, Siguret V, Mottier D; Innohep® in Renal Insufficiency Study Steering Committee; Leizorovicz A, Siguret V, Mottier D, Clonier F, Janas M, Stinson J, Townshend G, Maddalena M. Leizorovicz A, et al. Among authors: siguret v. Thromb Res. 2011 Jul;128(1):27-34. doi: 10.1016/j.thromres.2011.03.002. Epub 2011 Apr 7. Thromb Res. 2011. PMID: 21477846 Clinical Trial.
156 results